Drug profile · INN
c1 inhibitor (human)
CINRYZE
c1 inhibitor (human) (CINRYZE) is a coagulation factor xi inhibitor. Associated with Takeda.
EMA: approved Blood and blood forming organs (B06) B06AC01
Patents linked 0
Pipeline programs 12
News articles 0
Drug details — c1 inhibitor (human)
- Class
- Blood and blood forming organs (B06)
- Route
- —
- Patents
- 0
- Programs
- 12
- Data quality
- 0.89
Quick answer
c1 inhibitor (human) (CINRYZE) is a coagulation factor xi inhibitor. Associated with Takeda.
Key facts
INN c1 inhibitor (human)
Brand CINRYZE
Mechanism Coagulation factor XI inhibitor
Target Coagulation factor XI
Therapeutic class Blood and blood forming organs (B06)
ATC code B06AC01
Originator Takeda
Mechanism of action
Coagulation factor XI inhibitor
Primary target: Coagulation factor XI
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is c1 inhibitor (human)?
c1 inhibitor (human) (CINRYZE) is a coagulation factor xi inhibitor. Associated with Takeda.
What is the brand name for c1 inhibitor (human)?
CINRYZE is a marketed brand name for c1 inhibitor (human). Check FDA Drugs@FDA for the current US label holder and prescribing information.